A multicenter, randomized phase II study of neoadjuvant chemotherapy including trastuzumab with cyclophosphamide with docetaxel in patients with operable HER2-positive breast cancer (JBCRG-10 study).
2010 ◽
Vol 28
(15_suppl)
◽
pp. TPS105-TPS105